A and B and sulfurmycins A and B, new anthracycline antibiotics were discovered from the culture of a strain OBB-111, which was identified as Streptomyces galilaeus.
The structures of the antibiotics were determined, indicating that auramycins and sulfurmycins are anthracycline glycosides of new aglycones designated auramycinone and sulfurmycinone. 
Results and Discussions

Screening
From 60 soil samples, 768 colonies were picked as candidate pigment producers. These were streaked on agar medium and an agar block from each culture was tested for antibacterial activity against
Micrococcus luteus. The 374 strains with antibacterial activity and pigment production were flask cultured and their antibiotic principles were physicochemically characterized by examining solvent extractability, TLC mobility and UV spectral absorption at neutral, alkaline and acidic pH's.
As a result, strain OBB-111 was selected as a producer of anthracycline antibiotics. It was identified as Streptomyces galilaeus and named S. galilaeus OBB-111.
The culture filtrate of OBB-111 contained a yellow antibiotic complex consisting of several components as detected by TLC analyses and bioautography of the TLC plates. The antibiotic complex was extracted from the culture with a solvent mixture of chloroform and methanol (1: 1, v/v) and the major components were separated by TLC. The UV, IR, MS and NMR spectral data of the purified products were characteristic of anthracycline structures. The two major components appeared to be aclacinomycins A and B3). This was confirmed by direct comparison of physicochemical properties with authentic aclacinomycin A (a generous gift from Sanraku Ocean Co.). Besides aclacinomycins A and B, minor quantities of the related substances, MA144-Ml, -N1, -S1 and -T111) were also produced by strain OBB-111. On hydrolysis under stronger conditions, I gave auramycinone and rhodosamine.
Acetylation of II with acetic anhydride yielded two anomeric diacetates. The proton magnetic resonance spectrum of one of the anomers ( Fig. 6 ) was completely identical with data reported for the aanomer of a disaccharide diacetate obtained by similar treatment of cinerubin A13). Furthermore, treatment of auramycin A with methanol-HCI gave a methyl glycoside with spectral data coinciding with those reported for the methyl glycoside from aclacinomycin A14). These results, and a comparison of its properties with other data reported for aclacinomycin A14) indicated that auramycin A was L-
In a similar manner, the structure of sulfurmycin A was determined to be L-cinerulosyl-2-deoxy-L-fucosyl-L-rhodosaminyl sulfurmycinone ( Fig. 9 ). CMR spectra of auramycin A and sulfurmycin A are shown in Table 2 .
Structures of Auramycin B and Sulfurmycin B
On hydrolysis of auramycin B at room temperature, a yellow pigment III and a disaccharide IV were obtained. Hydrolysis of III under stronger conditions gave auramycinone and rhodosamine. Acetylation of IV with acetic anhydride in pyridine yielded two anomeric diacetates. Each was obtained pure after silica gel column chromatography. The 1H NMR spectrum of one ( Fig. 7) was identical with that of the p-anomer of a disaccharide acetate obtained by the same treatment of cinerubin B15) Similarly, the 1H NMR spectrum of the methyl glycoside (Fig. 8) which was obtained by methanolysis of auramycin B coincided with that reported for cinerubin B15). Thus, the structure of IV was concluded to be 2-deoxy-L-fucosyl-L-cinerulose B with the two sugars linked to each other in the same manner as in cinerubin B and aclacinomycin B (Fig. 9) . The CMR spectra of auramycin B and sulfurmycin B are shown in Table 2 .
Biological Activities
The antimicrobial activities of auramycins A and B and sulfurmycins A and B are shown in Table   3 . They showed marked antibacterial activity against Gram-positive bacteria and Mycobacterium smeginatis.
All the glycosides also exhibited antitumor activity against P388 and L1210 leukemia in mice at doses of 1.5~15 mg/kg/day administered intraperitoneally on days 1, 5 and 9.
Experimental General
Melting points were determined with a Yanagimoto micro melting point apparatus, type MP-S3, and were not corrected.
Infrared absorption spectra were measured with a Hitachi EPI-G3 spectrophotometer (KBr pellets) and mass spectra with a Hitachi RMU-6M spectrometer and JEOL JMS-D300 mass spectrometer. NMR spectra were recorded on a JEOL FX-100 spectrometer. Chemical shifts are given in a values with tetramethylsilane as an internal standard. Abbreviation: s=singlet, d= doublet, dd=doublet of doublets, t=triplet and m=multiplet. Optical rotations were determined using a Perkin-Elmer polarimeter.
For thin-layer chromatography, silica gel F254 plates, (Merck Co.) were used. For sugar analysis, the plates were sprayed with 5 % p-anisaldehyde and 5 % sulfuric acid in ethanol and heated at 90°C for color development.
Column chromatography was carried out with silica gel (Merck Co.), 0.063 to 0.2 mm, and Sephadex LH-20 (Pharmacia Fine Chemicals Co.). Preparative HPLC was carried out with a Prep PAK-500/ SILICA (Waters Associates, Inc.) column and Prep LC/System 500 (Waters).
Fermentation and Isolation
Spores scraped from an agar slant of Streptomyces galilaeus OBB-l 11 were transferred to 500-ml tore filtrate was extracted with 60 liters of chloroform -methanol (1: 1) mixture, and the chloroform layer was obtained. The chloroform extracts from cells and filtrate were combined and evaporated to a small volume (50~ 60 ml). The concentrate was diluted with n-hexane to precipitate yellow pigments, which were dried in vacuo to give 4.8 g of yellow powder. The crude antibiotic complex (4.8 g) was fractionated by Sephadex LH-20 column chromatography with a chloroform -methanol (2: 1) mixture. As a result, two distinct bands of yellow pigments were noted. The yellow solid (1.2 g) obtained from the first band consisted of aglycone-type pigments, which were subjected to silica gel column chromatography developed with a chloroform -n-hexane (4: 1) mixture. There were obtained 43 mg of 7-deoxysulfurmycinone, 68 mg of 7-deoxyauramycinone and 55 mg of 7-deoxyaklavinone (mp 230°C). The yellow solid (2.1 g) obtained from the second band consisted of auramycins, sulfurmycins and aclacinomycins. It was fractionated by column chromatography on silica gel using gradient elution with a chloroform -methanol mixture (100:0~95:5). To 100 mg of auramycin B in 15 ml of acetone was added 0.3 ml of concentrated hydrochloric acid. After standing for 120 minutes at room temperature, the reaction mixture was evaporated in vacuo. The residue was chromatographed, and gave 28 mg of yellow pigment (III), mp 139.5°C, and 23 mg of disaccharide (IV).
Hydrolysis of Yellow Pigment (I) Yellow pigment (I) (20 mg) was hydrolyzed in I ml of 0.1 N hydrochloric acid at 90'C for 60 minutes. The yellow precipitate was filtered off and dried to give 10 mg of auramycinone as a yellow powder, nip 153.5°C. The sugar in the filtrate was determined by TLC to be rhodosamine, mp 152°C.
Hydrolysis of Yellow Pigment (III)
Yellow pigment (Ill) (20 mg) was hydrolyzed in I ml of 0.1 N hydrochloric acid at 90°C for 60 minutes. From the reaction mixture, sulfurmycinone, mp 159°C, and rhodosamine, nip 152'C, were obtained.
Acetylation of Disaccharide (II) Disaccharide (II) (100 mg) obtained from auramycin A or sulfurmycin A was acetylated with acetic anhydride (2.0 ml) in pyridine (2.5 ml) for 16 hours at room temperature. The acetates were chromatographed by preparative TLC (cyclohexane -ethylacetate, 1 : 1) and gave two distinct bands, designated a-diacetate and 1-diacetate. From them, 25 mg of a-diacetate ([a],, -175°) and 32 mg of 1-diacetate ([a],, -120`) were obtained as colorless viscous liquids.
Acetylation of Disaccharide (IV) Disaccharide (IV) (100 mg) obtained from auramycin B or sulfurmycin B was acetylated with acetic anhydride (2.0 ml) in pyridine (2.5 ml) for 16 hours at room temperature. From the reaction mixture, 23 mg of a-acetate (nip 123°C) and 25 mg of ('-acetate (nip 188°C, [a]L1 -128°) were obtained as colorless crystals.
Partial Methanolysis Auramycin A: To a solution of auramycin A (200 mg) in 40 ml of dry acetone were added 2 ml of dry methanol and 1.5 ml of 0.2 N hydrochloric acid in absolute methanol. After 40 minutes at room temperature, the reaction mixture was concentrated in vacuo and the product was separated into yellow pigment (I) and crude methyl glycoside by column chromatography on silica gel. The crude
